MA42597A - 2-amino-3-fluoro-3-(fluorométhyl)-6-méthyl-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1 - Google Patents
2-amino-3-fluoro-3-(fluorométhyl)-6-méthyl-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1Info
- Publication number
- MA42597A MA42597A MA042597A MA42597A MA42597A MA 42597 A MA42597 A MA 42597A MA 042597 A MA042597 A MA 042597A MA 42597 A MA42597 A MA 42597A MA 42597 A MA42597 A MA 42597A
- Authority
- MA
- Morocco
- Prior art keywords
- tetrahydropyridines
- fluoromethyl
- fluoro
- phenyl
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201500465 | 2015-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA42597A true MA42597A (fr) | 2018-06-20 |
Family
ID=56615973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA042597A MA42597A (fr) | 2015-08-12 | 2016-08-10 | 2-amino-3-fluoro-3-(fluorométhyl)-6-méthyl-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1 |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US20180244645A1 (fr) |
| EP (1) | EP3334720A1 (fr) |
| JP (1) | JP2018531889A (fr) |
| KR (1) | KR20180033524A (fr) |
| CN (1) | CN107849011A (fr) |
| AR (1) | AR105668A1 (fr) |
| AU (1) | AU2016305275A1 (fr) |
| BR (1) | BR112017007472A2 (fr) |
| CA (1) | CA2993630A1 (fr) |
| CL (1) | CL2018000375A1 (fr) |
| CO (1) | CO2018000798A2 (fr) |
| CR (1) | CR20180077A (fr) |
| DO (1) | DOP2018000040A (fr) |
| EA (1) | EA201890256A1 (fr) |
| EC (1) | ECSP18010535A (fr) |
| HK (1) | HK1253372A1 (fr) |
| IL (1) | IL257007A (fr) |
| MA (1) | MA42597A (fr) |
| MX (1) | MX2018001699A (fr) |
| NI (1) | NI201800020A (fr) |
| PE (1) | PE20181015A1 (fr) |
| PH (1) | PH12018500268A1 (fr) |
| RU (1) | RU2018104868A (fr) |
| TN (1) | TN2018000035A1 (fr) |
| TW (1) | TW201718543A (fr) |
| WO (1) | WO2017025559A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3458B1 (ar) | 2014-11-10 | 2020-07-05 | H Lundbeck As | 2- أمينو-6- (دايفلوروميثيل) – 5، 5- ديفلورو-6-فينيل-3،4، 5، 6-تيتراهيدروبيريدين كمثبطات bace1 |
| CR20170187A (es) | 2014-11-10 | 2018-02-01 | H Lundbeck As | 2-Amino-3,5-difluoro-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas en calidad de inhibidores de BACE1 para el tratamiento de la enfermedad de Alzheimer |
| MA40941A (fr) | 2014-11-10 | 2017-09-19 | H Lundbeck As | 2-amino-5,5-difluoro-6-(fluorométhyl)-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1 |
| JO3627B1 (ar) | 2015-04-30 | 2020-08-27 | H Lundbeck As | إيميدازو بيرازينونات على هيئة مثبطات pde1 |
| TW201717948A (zh) | 2015-08-10 | 2017-06-01 | Ｈ 朗德貝克公司 | 包括給予２－胺基－３，５，５－三氟－３，４，５，６－四氫吡啶的聯合治療 |
| US10034861B2 (en) | 2016-07-04 | 2018-07-31 | H. Lundbeck A/S | 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors |
| BR112018013247A2 (pt) | 2016-10-28 | 2018-12-04 | H Lundbeck As | tratamentos de combinação compreendendo imidazopirazinonas para o tratamento de distúrbios psiquiátricos e/ou cognitivos |
| US10912773B2 (en) | 2016-10-28 | 2021-02-09 | H. Lundbeck A/S | Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors |
| BR112018017058A2 (pt) * | 2016-12-21 | 2019-07-02 | H Lundbeck As | 6-amino-5-fluoro-5-(fluorometil)-2,3,4,5-tetra-hidropiridin-2-il-fenil-5-(metóxi-d3)-pirazina-2-carboxamidas e derivados fluorados do mesmo como inibidores de bace1 |
| AR113926A1 (es) | 2017-12-14 | 2020-07-01 | H Lundbeck As | Derivados de 1h-pirazolo[4,3-b]piridinas |
| JP7261801B2 (ja) | 2017-12-14 | 2023-04-20 | ハー・ルンドベック・アクチエゼルスカベット | １ｈ－ピラゾロ［４，３－ｂ］ピリジンの投与を含む併用治療 |
| CN111511742B (zh) | 2017-12-20 | 2023-10-27 | H.隆德贝克有限公司 | 作为PDE1抑制剂的吡唑并[4,3-b]吡啶和咪唑并[1,5-a]嘧啶 |
| KR20210112968A (ko) | 2020-03-07 | 2021-09-15 | 장성환 | 양면 인쇄가 가능한 라벨 제조방법 |
| KR20230012296A (ko) | 2021-07-15 | 2023-01-26 | 장성환 | 양면 인쇄가 가능한 라벨 제조방법 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0210391A (pt) | 2001-06-12 | 2004-06-15 | Elan Pharm Inc | Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto |
| GB0124928D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
| EP1474395B1 (fr) | 2002-02-12 | 2007-10-17 | Smithkline Beecham Corporation | Derives de nicotinamide utiles comme inhibiteurs de p38 |
| AR077277A1 (es) | 2009-07-09 | 2011-08-17 | Lilly Co Eli | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer |
| CA2799640C (fr) | 2010-06-09 | 2018-10-16 | Janssen Pharmaceutica Nv | Derives de 5,6-dihydro-2h-[1,4]oxazin-3-ylamine utiles comme inhibiteurs de beta-secretase (bace) |
| EP2663559B1 (fr) | 2011-01-12 | 2015-07-01 | Novartis AG | Dérivés d'oxazine et leur utilisation dans le traitement de maladies neurologiques |
| AP3807A (en) | 2011-01-13 | 2016-09-30 | Novartis Ag | Novel heterocyclic derivatives and their use in the treatment of neurological disorders |
| US8754075B2 (en) | 2011-04-11 | 2014-06-17 | Hoffmann-La Roche Inc. | 1,3-oxazines as BACE1 and/or BACE2 inhibitors |
| EP2703399A4 (fr) | 2011-04-26 | 2014-10-15 | Shionogi & Co | Dérivé d'oxazine et inhibiteur de bace 1 le contenant |
| PE20140623A1 (es) | 2011-06-07 | 2014-05-30 | Hoffmann La Roche | Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace2 |
| UY34278A (es) | 2011-08-25 | 2013-04-05 | Novartis Ag | Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades |
| US8338413B1 (en) | 2012-03-07 | 2012-12-25 | Novartis Ag | Oxazine derivatives and their use in the treatment of neurological disorders |
| CA2867851A1 (fr) | 2012-03-20 | 2013-09-26 | Elan Pharmaceuticals, Inc. | Dihydro-thiazine spirocycliques et inhibiteurs de bace dihydro-oxazine et compositions et utilisations de ceux-ci |
| WO2014056816A1 (fr) | 2012-10-10 | 2014-04-17 | F. Hoffmann-La Roche Ag | Association d'un anticorps aβ et d'un inhibiteur de bace |
| EP2912035A4 (fr) | 2012-10-24 | 2016-06-15 | Shionogi & Co | Dérivés de dihydrooxazine ou d'oxazépine ayant une activité inhibitrice de bace1 |
| EP2961749B1 (fr) | 2013-03-01 | 2019-10-09 | Amgen Inc. | Composés perfluorés 5,6-dihydro-4h-1,3-oxazine-2-amine substitués en tant qu'inhibiteurs de la bêta-sécrétase et procédés d'utilisation correspondants |
| TWI639607B (zh) | 2013-06-18 | 2018-11-01 | 美國禮來大藥廠 | Ｂａｃｅ抑制劑 |
| EP3107897A1 (fr) | 2014-02-19 | 2016-12-28 | H. Lundbeck A/S | 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tétrahydropyridines utilisées en tant qu'inhibiteurs de bace1 dans le traitement de la maladie d'alzheimer |
| TW201623295A (zh) | 2014-04-11 | 2016-07-01 | 塩野義製藥股份有限公司 | 具有ｂａｃｅ１抑制活性之二氫噻及二氫衍生物 |
| MA40941A (fr) * | 2014-11-10 | 2017-09-19 | H Lundbeck As | 2-amino-5,5-difluoro-6-(fluorométhyl)-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1 |
| JO3458B1 (ar) * | 2014-11-10 | 2020-07-05 | H Lundbeck As | 2- أمينو-6- (دايفلوروميثيل) – 5، 5- ديفلورو-6-فينيل-3،4، 5، 6-تيتراهيدروبيريدين كمثبطات bace1 |
| CR20170187A (es) | 2014-11-10 | 2018-02-01 | H Lundbeck As | 2-Amino-3,5-difluoro-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas en calidad de inhibidores de BACE1 para el tratamiento de la enfermedad de Alzheimer |
| TW201717948A (zh) | 2015-08-10 | 2017-06-01 | Ｈ 朗德貝克公司 | 包括給予２－胺基－３，５，５－三氟－３，４，５，６－四氫吡啶的聯合治療 |
-
2016
- 2016-08-10 JP JP2018506847A patent/JP2018531889A/ja active Pending
- 2016-08-10 RU RU2018104868A patent/RU2018104868A/ru not_active Application Discontinuation
- 2016-08-10 BR BR112017007472A patent/BR112017007472A2/pt not_active Application Discontinuation
- 2016-08-10 CR CR20180077A patent/CR20180077A/es unknown
- 2016-08-10 US US15/751,765 patent/US20180244645A1/en not_active Abandoned
- 2016-08-10 EA EA201890256A patent/EA201890256A1/ru unknown
- 2016-08-10 PE PE2018000231A patent/PE20181015A1/es not_active Application Discontinuation
- 2016-08-10 MA MA042597A patent/MA42597A/fr unknown
- 2016-08-10 US US15/233,463 patent/US10011596B2/en not_active Expired - Fee Related
- 2016-08-10 TN TNP/2018/000035A patent/TN2018000035A1/en unknown
- 2016-08-10 AU AU2016305275A patent/AU2016305275A1/en not_active Abandoned
- 2016-08-10 TW TW105125417A patent/TW201718543A/zh unknown
- 2016-08-10 KR KR1020187004062A patent/KR20180033524A/ko unknown
- 2016-08-10 EP EP16748316.3A patent/EP3334720A1/fr not_active Withdrawn
- 2016-08-10 AR ARP160102458A patent/AR105668A1/es unknown
- 2016-08-10 CN CN201680045234.5A patent/CN107849011A/zh active Pending
- 2016-08-10 WO PCT/EP2016/069029 patent/WO2017025559A1/fr active Application Filing
- 2016-08-10 MX MX2018001699A patent/MX2018001699A/es unknown
- 2016-08-10 CA CA2993630A patent/CA2993630A1/fr not_active Abandoned
-
2018
- 2018-01-18 IL IL257007A patent/IL257007A/en unknown
- 2018-01-26 CO CONC2018/0000798A patent/CO2018000798A2/es unknown
- 2018-02-05 PH PH12018500268A patent/PH12018500268A1/en unknown
- 2018-02-06 NI NI201800020A patent/NI201800020A/es unknown
- 2018-02-08 DO DO2018000040A patent/DOP2018000040A/es unknown
- 2018-02-09 EC ECIEPI201810535A patent/ECSP18010535A/es unknown
- 2018-02-09 CL CL2018000375A patent/CL2018000375A1/es unknown
- 2018-10-03 HK HK18112668.6A patent/HK1253372A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12018500268A1 (en) | 2018-08-13 |
| ECSP18010535A (es) | 2018-04-30 |
| EA201890256A1 (ru) | 2018-06-29 |
| PE20181015A1 (es) | 2018-06-26 |
| CR20180077A (es) | 2018-04-09 |
| HK1253372A1 (zh) | 2019-06-14 |
| RU2018104868A (ru) | 2019-09-13 |
| CA2993630A1 (fr) | 2017-02-16 |
| IL257007A (en) | 2018-03-29 |
| CO2018000798A2 (es) | 2018-05-10 |
| WO2017025559A1 (fr) | 2017-02-16 |
| CN107849011A (zh) | 2018-03-27 |
| AU2016305275A1 (en) | 2018-02-08 |
| TW201718543A (zh) | 2017-06-01 |
| CL2018000375A1 (es) | 2018-07-06 |
| DOP2018000040A (es) | 2018-04-30 |
| EP3334720A1 (fr) | 2018-06-20 |
| US20170044151A1 (en) | 2017-02-16 |
| NI201800020A (es) | 2018-06-29 |
| MX2018001699A (es) | 2018-05-07 |
| US20180244645A1 (en) | 2018-08-30 |
| BR112017007472A2 (pt) | 2018-01-23 |
| US10011596B2 (en) | 2018-07-03 |
| AR105668A1 (es) | 2017-10-25 |
| KR20180033524A (ko) | 2018-04-03 |
| TN2018000035A1 (en) | 2019-07-08 |
| JP2018531889A (ja) | 2018-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA42597A (fr) | 2-amino-3-fluoro-3-(fluorométhyl)-6-méthyl-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1 | |
| IL272407A (en) | Molecules for use in pest control, and intermediates, preparations, and related processes | |
| MA45591A (fr) | Dérivés de 1,3-dihydroxy-phényle utiles comme immunomodulateurs | |
| MA43761A (fr) | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides comme inhibiteurs de la apj | |
| MA41251A (fr) | Dérivés de thiéno[2,3-c]pyrrol-4-one comme inhibiteurs erk | |
| HRP20181698T1 (hr) | 2-amino-6-(difluormetil)-5,5-difluor-6-fenil-3,4,5,6-tetrahidropiridini kao inhibitori bace1 | |
| MA40941A (fr) | 2-amino-5,5-difluoro-6-(fluorométhyl)-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1 | |
| MA41977A (fr) | Imidazopyrazinones utilisées comme inhibiteurs de pde1 | |
| IL252195B (en) | Molecules with use in pest control, and intermediate products, preparations and processes related to them | |
| ZA201701131B (en) | Novel 2,5-substituted pyrimidines as pde4 inhibitors | |
| EP3273075A4 (fr) | Organe de fixation | |
| EP3223820A4 (fr) | Composés iminopyrimidinones condensés oxacycliques en c5-c6 utilisés comme inhibiteurs de bace, compositions et utilisation associées | |
| EP3388693A4 (fr) | Clip | |
| HK1247927A1 (zh) | 新型組合物、用途及其製備方法 | |
| EP3368519A4 (fr) | Nouveaux antioestrogènes hétérocycliques | |
| FR3025204B1 (fr) | Copolymeres a blocs utilisables comme fluidifiants | |
| DK3237407T3 (da) | 3,5-diaminopyrazolkinasehæmmere | |
| GB201513614D0 (en) | Compositions, compounds and methods and uses relating thereto | |
| EP3191447A4 (fr) | Composés de s-imino-s-oxo iminothiazine en tant qu'inhibiteurs de bace, compositions, et leur utilisation | |
| EP3274089A4 (fr) | Composition de catalyseur présulfuré | |
| EP3118227A4 (fr) | Composition de 1-octène | |
| MA42604A (fr) | 2-amino-7a-phényl-3,4,4a,5,7,7a-hexahydrofuro[3,4-b]pyridines comme inhibiteurs de bace1 | |
| PT3335729T (pt) | Composição de etanercept com estabilidade melhorada | |
| ES1146958Y (es) | Lama de persiana. | |
| AU2015901323A0 (en) | Slag notch |